Mumbai: Welcome Cure has raised over 4 Crores in the Pre-series A Round led by Inflection Point Ventures (IPV). The funds will be utilized for growth, including talent acquisition, technology enhancement, and marketing initiatives. IPV has led the round, and Welcome Cure is looking at raising over 16 crores in this ongoing funding round.
Welcome Cure is a fully integrated Homeopathy Technology company that offers Assisted intelligence (AI)-powered solutions for doctors and patients, ensuring both effective prescriptions and convenient access to healthcare regardless of location.
- The funds will be utilized for growth, including talent acquisition, technology enhancement and marketing initiatives.
- Inflection Point Ventures (IPV) has so far invested over INR 600 Cr across 190+ deals.
Welcome Cure addresses the growing demand for sustainable and holistic healthcare by providing a comprehensive one-stop solution in the fragmented homoeopathy market, offering convenient online and offline services for diagnosis, treatment, and monitoring, with a focus on prevention and overall well-being.
A team of experienced and accomplished individuals leads Welcome Cure. Dr Jawahar Shah, the Founder, brings 45 years of clinical practice as an MD in Homeopathy and holds a post-graduate degree from London. Punit Desai, the Co-founder and CEO, contributes his expertise with an MBA and over ten years of entrepreneurship experience. Nidhi Desai, the Co-founder and COO, also brings an MBA and over 10 years of entrepreneurship experience to the team. Together, they form a strong leadership that drives Welcome Cure’s mission to provide holistic healthcare solutions through their innovative platform.
Vikram Ramasubramanian, Partner, Inflection Point Ventures, says, “While Homeopathy treatment is well recognised across the globe, the number of people opting for such treatment is also growing exponentially. The main reason for such acceptance is the ability to provide treatment to the root cause, especially chronic disease, which is recurring and needs utmost attention. Welcomecure, with its unique healthcare solution, has been able to offer its patients much-needed treatment regardless of location. The brand itself has grown multi-folds with its ability to offer seamless interaction between its patients and doctors, onboard the best caregivers and experts in homoeopathic medicine and provide a holistic solution all under a roof. We at IPV look forward to scaling their new age business with strategic guidance and enabling the brand to benefit more and more individuals”.
Welcome Cure operates at an impressive scale, with 2.5 million platform users and 1.5 million+ registered patients in 36+ countries. Their software business serves over 1 lakh doctors in 140+ countries.
Welcome Cure stands out in the healthcare industry with its modernized homoeopathy and holistic care solutions, catering to patients’ needs in a comprehensive manner. Their unique proposition lies in the integration of proprietary Assisted Intelligence (AI) solutions, which serve as a valuable decision support system for physicians. This AI-powered technology enhances diagnostic accuracy, treatment selection, and monitoring, ensuring optimal patient care. Welcome! Cure’s commitment to an integrated and 360-degree technology-powered solution further solidifies its position as a leader in the homoeopathy domain.
Dr. Jawahar Shah, Founder of Welcome Cure, says, “Homeopathy has been around for more than 200 years, grown consistently and served humanity. It enjoys acceptance from all socio-economic classes and has a wide presence across the world. As per WHO, it is the 2nd largest system of medicine and used in over 100 countries. In a $9 Billion+ market, there is immense potential as it’s growing at over 18% CAGR, and there is a missing brand, which is a name synonym to Homeopathy. Welcome Cure desires to do that and be that. Emerge is the 1st choice when anyone thinks of Homeopathy Care. With IPV participation in Welcome Cure as an equity and growth investor, we are poised to make this vision come to light.”
Welcome Cure has achieved remarkable organic growth since its inception, with a positive return for the past two years. Within the last couple of years alone, the company has achieved a cumulative business of over 45+ crores, demonstrating its strong presence in the Alternative Medicine space. The startup and its founders have also received recognition and accolades from esteemed institutions and bodies, including testimonials and awards from Prime Minister Narendra Modi, the Ministry of Electronics & IT, and other prestigious organizations.
The Homeopathy industry is currently valued at over 7 billion USD and is experiencing a growth rate of 18% CAGR (Compound Annual Growth Rate). Projections indicate that the industry is expected to surpass 21 billion USD within the next 5 to 7 years, indicating significant growth potential in the near future.
About Welcome Cure:
Welcome Cure is a fully integrated Homeopathy Technology company with a proprietary Assisted Intelligence (AI) powered solution for doctors. The brand also serves patients across the globe with holistic care solutions via its telemedicine platform. The start-up has served 2.5 million Patients in 36+ countries via its proprietary Telemedicine platform. The software business division has catered to over 100K+ doctors in 140+ countries with mobile applications and decision support system software.
About Inflection Point Ventures & Physis Capital:
Inflexion Point Ventures (IPV) is an angel investing platform with over 8600 CXOs, HNIs, and Professionals to invest together in startups. The firm supports new-age entrepreneurs by providing them with monetary & experiential capital and connecting them with a diverse group of investors. IPV has announced the launch of a $50 million CAT 2 AIF Physis Capital to invest in pre-Series A to Series B growth-stage start-ups.
